← Issue №15/ week of Oct 11, 2026/Colorectal

Consensus guidance of immune checkpoint inhibitors in locally advanced rectal cancer.

From GI Signals issue №15: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Colorectal guideline · Oct 7, 2026 · Gut · IF 24.6

Consensus guidance of immune checkpoint inhibitors in locally advanced rectal cancer.

Guideline / reviewguidelinecolorectal cancermicrosatellite instability
Clinical takeawayConsider integrating perioperative immunotherapy and organ-preserving strategies into treatment plans for LARC patients, guided by the consensus recommendations. Ensure multidisciplinary team involvement, adherence to mismatch repair/microsatellite instability detection standards, and monitor for safety signals related to perioperative immunotherapy.
What it foundThe consensus provides graded recommendations for preoperative immunotherapy duration, postoperative adjuvant therapy, local resection, and organ preservation strategies in locally advanced rectal cancer (LARC), based on key clinical trials and emphasizing multidisciplinary team involvement.
ContextThis consensus refines and updates perioperative and organ-preserving treatment strategies for LARC, building on recent clinical trial evidence and addressing gaps in prior guidelines, with a focus on safety and efficacy.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Yang Z … Chinese Society of Colorectal Surgery CNSCRS · Gut · IF 24.6 · PubMed ↗Permalink
← Read the whole of issue №15 Every paper GI Signals surfaces gets a page like this one. All issues